Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-01-10T22:15:44.306Z Has data issue: false hasContentIssue false
  • English
  • Français

Risk Factors for Candidemia in Pediatric Patients With Congenital Heart Disease

Published online by Cambridge University Press:  21 June 2016

Lucía García-San Miguel ,
Javier Cobo ,
Isabel Martos ,
Enrique Otheo ,
Alfonso Muriel ,
Vicente Pintado  and
Santiago Moreno
Lucía García-San Miguel*
Affiliation:
Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain
Javier Cobo
Affiliation:
Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain
Isabel Martos
Affiliation:
Pediatric Intensive Care Unit, Ramón y Cajal Hospital, Madrid, Spain
Enrique Otheo
Affiliation:
Pediatric Intensive Care Unit, Ramón y Cajal Hospital, Madrid, Spain
Alfonso Muriel
Affiliation:
Biostatistics Unit, Ramón y Cajal Hospital, Madrid, Spain
Vicente Pintado
Affiliation:
Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain
Santiago Moreno
Affiliation:
Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain
*
Hospital Ramón y Cajal, Servicio de Enfermedades Infecciosas, Carretera de Colmenar Km 9,100, Madrid 28034, Spain ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To identify the main risk factors for the acquisition of candidemia in children with congenital heart disease (CHD) in order to improve the clinical management of these patients.

Design.

A case-control study.

Setting.

A large tertiary-care referral center in Spain with a pediatric intensive care unit (PICU) to which more than 500 children with CHD are admitted annually.

Patients.

All patients had CHD and were admitted to the PICU during 1995-2000. Case patients were defined as patients with candidemia, and control patients were defined as patients without candidemia.

Results.

Twenty-eight case patients and 47 control subjects were included in the study. Case patients were younger (mean age [ ± SD], 12.5 ± 32.0 vs 38.0 ± 48.0 months; P< .01) and had a longer median PICU stay (19 vs 4 days; P < .01), and a greater percentage of case patients previously had Candida species isolated from specimens other than blood (eg, bronchial aspirates, urine, or skin specimens) (39% vs 4%; P<.01). Severity of clinical condition, as measured by the Therapeutic Intervention Scoring System (TISS) 1 week after PICU admission (odds ratio, 1.15; 95% confidence interval, 1.05-1.26; P<.01), and receipt of antibiotic treatment for more than 5 days (odds ratio, 13.42; 95% confidence interval, 1.31-137.13; P = .03) were independently associated with the development of candidemia.

Conclusions.

Patients with CHD who have a high TISS score 1 week after PICU admission and patients who have received prolonged antibiotic therapy should be considered at high risk for candidemia. Our results suggest that shorter courses of antibiotic therapy, routine surveillance culture for Candida species, and initiation of preemptive or empirical antifungal treatment could help in the clinical management of these patients.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 6 , June 2006 , pp. 576 - 580
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Beck Sague, C, Jarvis, WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167:1247–1251.Google Scholar
2.García-San Miguel, L, Pla, J, Cobo, J, Navarro, F, Sánchez-Sousa, A, Alvarez, ME, Martos, I, Moreno, S. Morphotypic and genotypic characterization of sequential C. parapsilosis isolates from an outbreak in a pediatric intensive care unit. Diagn Microbiol Infect Dis 2004; 49:189–196.CrossRefGoogle Scholar
3.Kossoff, EH, Buescher, ES, Karlowicz, MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17:504–508.Google Scholar
4.Rennert, G, Rennert, HS, Pitlik, S, Finkelstein, R, Kitzes-Cohen, R. Epidemiology of candidemia: a nationwide survey in Israel. Infection 2000; 28:26–29.Google Scholar
5.Saiman, L, Ludington, E, Pfaller, M, et al. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 2000; 19:319–324.Google Scholar
6.García-San Miguel, L, Cobo, J, Otheo, E, Sánchez-Sousa, A, Abraira, V, Moreno, S. Secular trends of candidemia in a large tertiary hospital (19882000): the emergence of C. parapsilosis. Infect Control Hosp Epidemiol 2005; 26:548–552.Google Scholar
7.Jarvis, WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20:1526–1530.Google Scholar
8.Stamos, JK, Rowley, AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20:571–575.Google Scholar
9.Chakrabarti, C, Sood, SK, Parnell, V, Rubin, LG. Prolonged candidemia in infants following surgery for congenital heart disease. Infect Control Hosp Epidemiol 2003; 24:753–757.Google Scholar
10.Keene, AR, Cullen, DJ. Therapeutic Intervention Scoring System: update 1983. Crit Care Med 1983; 11:1–3.Google Scholar
11.Pollack, MM, Ruttimann, UE, Getson, PR. Pediatric Risk of Mortality (PRISM) score. Crit Care Med 1988; 16:1110–1116.Google Scholar
12.Dugan, C. Nutritional assessment and requirements. In: Walter, WA, Durie, PR, Hamilton, JR, Walter-Smith, JA, Watkins, JB, eds. Pediatric Gastrointestinal Disease. 3rd ed. Hamilton, Canada: BC Decker; 2000:1691–1705.Google Scholar
13.Voss, A, Hollis, RJ, Pfaller, MA, Wenzel, RP, Doebbeling, BN. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994; 32:975–980.Google Scholar
14.Bonten, MJM, Gaillard, CA, Johanson, WG, et al. Colonization in patients receiving and not receiving topical antimicrobial prophylaxis. Am J Respir Crit Care Med 1994; 150:1332–1340.Google Scholar
15.Martino, P, Girmenia, C, Micozzi, A, De Bernardis, F, Boccanera, M, Cassone, A. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. Eur J Clin Microbiol Infect Dis 1994; 13:797–804.Google Scholar
16.Abraira, V, Pérez de Vargas, A. Método Multivariante en Bioestadtstíca. Madrid: Editorial Centra de Estudios Ramón Areces; 1996.Google Scholar
17.Fraser, VJ, Jones, M, Dunkel, J, Storfer, S, Medoff, G, Dunagan, WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15:414–421.CrossRefGoogle Scholar
18.Harvey, RL, Myers, JP. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 1987; 147:2117–2120.Google Scholar
19.Horn, R, Wong, B, Kiehn, TE, Armstrong, D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7:646–655.Google Scholar
20.Komshian, SV, Uwaydah, AK, Sobel, JD, Crane, LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11:379–390.Google Scholar
21.Levy, I, Rubin, LG, Vasishtha, S, Tucci, V, Sood, SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998; 26:1086–1088.CrossRefGoogle ScholarPubMed
22.MacDonald, L, Baker, C, Chenoweth, C. Risk factors for candidemia in a children's hospital. Clin Infect Dis 1998; 26:642–645.CrossRefGoogle ScholarPubMed
23.Micek, ST, Ward, S, Fraser, VS, Kollef, MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004; 125:1791–1799.CrossRefGoogle ScholarPubMed